Publication: Dapsone-induced severe cutaneous adverse drug reactions are strongly linked with HLA-B ∗ 13:01 allele in the Thai population
2
Issued Date
2017-01-01
Resource Type
ISSN
17446880
17446872
17446872
Other identifier(s)
2-s2.0-85032934701
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Pharmacogenetics and Genomics. Vol.27, No.12 (2017), 429-437
Suggested Citation
Therdpong Tempark, Patompong Satapornpong, Pawinee Rerknimitr, Nontaya Nakkam, Niwat Saksit, Penpun Wattanakrai, Thawinee Jantararoungtong, Napatrupron Koomdee, Ajanee Mahakkanukrauh, Wichittra Tassaneeyakul, Sumitra Suttisai, Jirawat Pratoomwun, Jettanong Klaewsongkram, Ticha Rerkpattanapipat, Chonlaphat Sukasem Dapsone-induced severe cutaneous adverse drug reactions are strongly linked with HLA-B ∗ 13:01 allele in the Thai population. Pharmacogenetics and Genomics. Vol.27, No.12 (2017), 429-437. doi:10.1097/FPC.0000000000000306 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/42061
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Dapsone-induced severe cutaneous adverse drug reactions are strongly linked with HLA-B ∗ 13:01 allele in the Thai population
Author(s)
Therdpong Tempark
Patompong Satapornpong
Pawinee Rerknimitr
Nontaya Nakkam
Niwat Saksit
Penpun Wattanakrai
Thawinee Jantararoungtong
Napatrupron Koomdee
Ajanee Mahakkanukrauh
Wichittra Tassaneeyakul
Sumitra Suttisai
Jirawat Pratoomwun
Jettanong Klaewsongkram
Ticha Rerkpattanapipat
Chonlaphat Sukasem
Patompong Satapornpong
Pawinee Rerknimitr
Nontaya Nakkam
Niwat Saksit
Penpun Wattanakrai
Thawinee Jantararoungtong
Napatrupron Koomdee
Ajanee Mahakkanukrauh
Wichittra Tassaneeyakul
Sumitra Suttisai
Jirawat Pratoomwun
Jettanong Klaewsongkram
Ticha Rerkpattanapipat
Chonlaphat Sukasem
Abstract
© 2017 Wolters Kluwer Health, Inc. All rights reserved. Objectives A previous publication in Chinese leprosy patients showed that the HLA-B∗13:01 allele is a strong genetic marker for dapsone-induced drug hypersensitivity reactions, however there are no data describing whether HLA-B∗13:01 is a valid marker for prediction of dapsone-induced drug hypersensitivity reactions in other ethnicities or nonleprosy patients. The aim of this study is to investigate whether there is an association between HLA genotypes and dapsone-induced severe cutaneous adverse reactions (SCARs) in Thai nonleprosy patients. Patients and methods HLA-B genotypes of 15 patients with dapsone-induced SCARs (11 drug reaction with eosinophilia and systemic symptoms, 4 Stevens-Johnson syndrome/toxic epidermal necrolysis), 29 control patients, and 986 subjects from the general Thai population were determined by the reverse PCR sequence-specific oligonucleotides probe. Results The HLA-B∗13:01 allele was significantly associated with dapsone-induced SCARs compared with dapsone-tolerant controls (odds ratio: 54.00, 95% confidence interval: 7.96-366.16, P=0.0001) and the general population (odds ratio: 26.11, 95% confidence interval: 7.27-93.75, P=0.0001). In addition, HLA-B∗13:01 associated with dapsone-induced SJS-TEN (OR: 40.50, 95% confidence interval: 2.78-591.01, P=0.0070) and DRESS (OR: 60.75, 95% confidence interval: 7.44-496.18, P=0.0001). Conclusion This study demonstrated an association between HLA-B∗13:01 and dapsone-induced SCARs including Stevens-Johnson syndrome/toxic epidermal necrolysis and drug reaction with eosinophilia and systemic symptoms in nonleprosy patients. Moreover, these results suggest that the HLA-B∗13:01 allele may be a useful genetic marker for prediction of dapsone-induced SCARs in Thai and Han-Chinese populations.